BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6267402)

  • 1. Naloxazone irreversibly inhibits the high affinity binding of [125I]D-ala2-D-leu5-enkephalin.
    Hazum E; Chang KJ; Cuatrecasas P; Pasternak GW
    Life Sci; 1981 Jun; 28(26):2973-9. PubMed ID: 6267402
    [No Abstract]   [Full Text] [Related]  

  • 2. Classification of multiple morphine and enkephalin binding sites in the central nervous system.
    Wolozin BL; Pasternak GW
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6181-5. PubMed ID: 6273857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding and metabolism studies with [3H](D-Ala2,Leu5)enkephalinamide and [3H](D-Ala2,Pro5)enkephalinamide: evidence for a selective interaction of (D-Ala2,Pro5)enkephalinamide with mu-receptors.
    Audigier Y; Mazarguil H; Roy J; Morgat JL; Cros J
    Eur J Pharmacol; 1981 Sep; 74(4):273-8. PubMed ID: 6271558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective protection of stereospecific enkephalin and opiate binding against inactivation by N-ethylmaleimide: evidence for two classes of opiate receptors.
    Smith JR; Simon EJ
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):281-4. PubMed ID: 6244551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed type inhibition of [D-Ala2, D-Leu5]enkephalin binding to mu-opiate binding sites by mu-, but not by kappa-opiate ligands.
    Pfeiffer A; Herz A
    Eur J Pharmacol; 1982 Feb; 77(4):359-61. PubMed ID: 6277680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the binding characteristics of tritiated opiates and opioid peptides.
    Gillan MG; Kosterlitz HW; Paterson SJ
    Br J Pharmacol; 1980 Nov; 70(3):481-90. PubMed ID: 7437652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
    Cruciani RA; Lutz RA; Munson PJ; Rodbard D
    J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple morphine and enkephalin receptors: biochemical and pharmacological aspects.
    Pasternak GW
    Ann N Y Acad Sci; 1986; 467():130-9. PubMed ID: 3014970
    [No Abstract]   [Full Text] [Related]  

  • 10. The actions of naloxazone on the binding and analgesic properties of morphiceptin (NH2Tyr-Pro-Phe-Pro-CONH2), a selective mu-receptor ligand.
    Zhang AZ; Chang JK; Pasternak GW
    Life Sci; 1981 Jun; 28(25):2829-36. PubMed ID: 6267398
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential postnatal development of mu and delta opiate receptors.
    Wohltmann M; Roth BL; Coscia CJ
    Brain Res; 1982 Apr; 255(4):679-84. PubMed ID: 6280810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric modulation by leucine-enkephalin of [3H]naloxone binding in rat brain.
    Rothman RB; Westfall TC
    Eur J Pharmacol; 1981 Jul; 72(4):365-8. PubMed ID: 6268425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metkephamid (Tyr-D-ala-Gly-Phe-N(Me)Met-NH2), a potent opioid peptide: receptor binding and analgesic properties.
    Burkhardt C; Frederickson RC; Pasternak GW
    Peptides; 1982; 3(5):869-71. PubMed ID: 6294639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiate receptor heterogeneity in human brain regions.
    Bonnet KA; Groth J; Gioannini T; Cortes M; Simon EJ
    Brain Res; 1981 Sep; 221(2):437-40. PubMed ID: 6269694
    [No Abstract]   [Full Text] [Related]  

  • 15. Analgesic activity of intracerebroventricular administration of morphiceptin and beta-casomorphins: correlation with the morphine (micro) receptor binding affinity.
    Chang KJ; Cuatrecasas P; Wei ET; Chang JK
    Life Sci; 1982 May; 30(18):1547-51. PubMed ID: 6281604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between enkephalin degradation and opiate receptor occupancy.
    Knight M; Klee WA
    J Biol Chem; 1978 Jun; 253(11):3843-7. PubMed ID: 25892
    [No Abstract]   [Full Text] [Related]  

  • 17. Alterations in the binding of [3H]leucine-enkephalin to striatal membranes by endogenous factors.
    Rothman RB; Westfall TC
    J Neurochem; 1979 Jul; 33(1):191-200. PubMed ID: 222879
    [No Abstract]   [Full Text] [Related]  

  • 18. 14 beta-(Bromoacetamido)morphine irreversibly labels mu opioid receptors in rat brain membranes.
    Bidlack JM; Frey DK; Seyed-Mozaffari A; Archer S
    Biochemistry; 1989 May; 28(10):4333-9. PubMed ID: 2548575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific protection of the binding sites of D-Ala2-D-Leu5-enkephalin (delta-receptors) and dihydromorphine (mu-receptors).
    Robson LE; Kosterlitz HW
    Proc R Soc Lond B Biol Sci; 1979 Aug; 205(1160):425-32. PubMed ID: 41257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors.
    Mosberg HI; Hurst R; Hruby VJ; Gee K; Yamamura HI; Galligan JJ; Burks TF
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):5871-4. PubMed ID: 6310598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.